Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study

ConclusionAmong all patients stable on IFN beta therapy and the subset stable on IM IFN beta therapy in particular, those who remained on therapy had significantly better outcomes than those who switched to another IFN beta therapy.FundingBiogen (Cambridge, MA, USA).
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research